Aurobindo Announces Surprise Deal As COVID-19 Vaccine Progresses
Phase III Trials Of COVID-19 Vaccine Set To Begin
While its COVID-19 vaccine, partnered with US-based Vaxxinity, is set to move to Phase III trials, Aurobindo has acquired an animal health company as well as several ANDAs and OTC assets. The acquisition and a deceleration in US sales caught analysts by surprise.
